INTERNATIONAL PATENT: REGENECORE BIOTECH CO., LTD, 南京融捷康生物科技有限公司 FILES APPLICATION FOR "ANTI-CD33 SINGLE-DOMAIN ANTIBODY, ANTI-CD123 ANTIBODY, POLYPEPTIDE TARGETING CD33 AND CD123 MOLECULES AND USE THEREOF"

GENEVA, Aug. 17 -- REGENECORE BIOTECH CO., LTD (Building 07, 16 Tree-House, Tanmi Rd., Jiangbei New AreaNanjing, Jiangsu 210000), 南京融捷康生物科技有限公司 (中国江苏省南京市江北新区探秘路树屋十六栋、07栋) filed a patent application (PCT/CN2024/142262) for "ANTI-CD33 SINGLE-DOMAIN ANTIBODY, ANTI-CD123 ANTIBODY, POLYPEPTIDE TARGETING CD33 AND CD123 MOLECULES, AND USE THEREOF" on Dec 25, 2024. With publication no. WO/2025/167373, the details related to the patent application was published on Aug 14, 2025.

Notably, the patent applicatio...